These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12668501)

  • 21. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia.
    Zucco L; Zhang Q; Kuliszewski MA; Kandic I; Faughnan ME; Stewart DJ; Kutryk MJ
    PLoS One; 2014; 9(2):e89927. PubMed ID: 24587130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
    Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M
    Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular genetics of hereditary hemorrhagic telangiectasia.
    Marchuk DA
    Chest; 1997 Jun; 111(6 Suppl):79S-82S. PubMed ID: 9184539
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of hereditary hemorrhagic telangiectasia and hereditary nonpolyposis colorectal cancer in the same kindred.
    Goldschmidt N; Metzger S; Wexler ID; Goldshmidt O; Hershcovici T; Chajek-Shaul T
    Int J Cancer; 2005 Sep; 116(5):808-12. PubMed ID: 15849752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
    Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W
    Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective angiogenesis in mice lacking endoglin.
    Li DY; Sorensen LK; Brooke BS; Urness LD; Davis EC; Taylor DG; Boak BB; Wendel DP
    Science; 1999 May; 284(5419):1534-7. PubMed ID: 10348742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular morphogenesis: tales of two syndromes.
    Marchuk DA; Srinivasan S; Squire TL; Zawistowski JS
    Hum Mol Genet; 2003 Apr; 12 Spec No 1():R97-112. PubMed ID: 12668602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
    Seki T; Yun J; Oh SP
    Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin has a crucial role in blood cell-mediated vascular repair.
    van Laake LW; van den Driesche S; Post S; Feijen A; Jansen MA; Driessens MH; Mager JJ; Snijder RJ; Westermann CJ; Doevendans PA; van Echteld CJ; ten Dijke P; Arthur HM; Goumans MJ; Lebrin F; Mummery CL
    Circulation; 2006 Nov; 114(21):2288-97. PubMed ID: 17088457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
    McAllister KA; Grogg KM; Johnson DW; Gallione CJ; Baldwin MA; Jackson CE; Helmbold EA; Markel DS; McKinnon WC; Murrell J
    Nat Genet; 1994 Dec; 8(4):345-51. PubMed ID: 7894484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1.
    Galaris G; Montagne K; Thalgott JH; Goujon GJPE; van den Driesche S; Martin S; Mager HJ; Mummery CL; Rabelink TJ; Lebrin F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension.
    Chaouat A; Coulet F; Favre C; Simonneau G; Weitzenblum E; Soubrier F; Humbert M
    Thorax; 2004 May; 59(5):446-8. PubMed ID: 15115879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia.
    Llorca O; Trujillo A; Blanco FJ; Bernabeu C
    J Mol Biol; 2007 Jan; 365(3):694-705. PubMed ID: 17081563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supermodels and disease: insights from the HHT mice.
    Shovlin CL
    J Clin Invest; 1999 Nov; 104(10):1335-6. PubMed ID: 10562293
    [No Abstract]   [Full Text] [Related]  

  • 39. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function.
    McAllister KA; Baldwin MA; Thukkani AK; Gallione CJ; Berg JN; Porteous ME; Guttmacher AE; Marchuk DA
    Hum Mol Genet; 1995 Oct; 4(10):1983-5. PubMed ID: 8595426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.